Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Read on for a closer look at the science behind these drugs and the different opinions surrounding their increasingly popular role in weight loss
GLP1 medications mimic a natural hormone called glucagon-like peptide-1 (GLP1), which helps control: Appetite and fullness (signals fullness to the brain) Digestion (slows the movement of food in the stomach) Blood sugar (to maintain a normal level) As you can imagine, when consuming more of this hormone, these messages happen more quickly, leading to the symptoms that you may be experiencing: Feeling full for longer: resulting in less food intake, and often, weight loss Nausea: can be caused from food staying in the stomach for longer Fatigue: may be related to lower sugars in the blood and less food intake The Nutritional Risks of Eating Less (and Why They Sneak Up on You) All of these symptoms point to less food intake
Podcast Description Join ASAM Practice Pearls for in-depth discussions on addiction prevention, treatment, and recovery
GI adaptation: Lower doses allow the digestive system to adjust, reducing nausea and vomiting Triple receptor activation: Retatrutide's unique GLP-1/GIP/glucagon mechanism requires gradual introduction Safety monitoring: Assess individual response before increasing to therapeutic doses Injection site tolerance: Verify no local reactions before committing to higher doses What to Expect in the First Week During the initial retatrutide dose, you may experience: Mild appetite reduction (typically noticeable by days 2-3) Possible nausea, especially with large or fatty meals Minor injection site reaction (redness, mild swelling) Increased satiety after smaller portions Important: Don't be discouraged if you don't see significant weight loss at 2mg
